HealthEquity (HQY) Projected to Post Quarterly Earnings on Tuesday

HealthEquity (NASDAQ:HQY) is anticipated to issue its quarterly earnings data after the market closes on Tuesday, March 18th. Analysts expect the company to announce earnings of $0.71 per share and revenue of $306.12 million for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

HealthEquity Stock Performance

Shares of HQY stock opened at $97.41 on Monday. The company has a market cap of $8.44 billion, a price-to-earnings ratio of 89.37, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity has a 52 week low of $65.01 and a 52 week high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a 50 day moving average of $105.68 and a 200-day moving average of $95.35.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.20% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Mizuho assumed coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. Barrington Research restated an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a research note on Friday. JMP Securities boosted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Wells Fargo & Company boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Finally, Raymond James boosted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday, February 25th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $112.92.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.